Ginkgo Bioworks Inc. (DNA)
Bid | 7.48 |
Market Cap | 442.21M |
Revenue (ttm) | 237.42M |
Net Income (ttm) | -472.07M |
EPS (ttm) | -8.91 |
PE Ratio (ttm) | -0.85 |
Forward PE | -1.78 |
Analyst | Sell |
Ask | 7.58 |
Volume | 632,704 |
Avg. Volume (20D) | 1,251,503 |
Open | 7.74 |
Previous Close | 7.48 |
Day's Range | 7.49 - 7.78 |
52-Week Range | 5.00 - 22.60 |
Beta | 1.29 |
Analyst Forecast
According to 0 analyst ratings, the average rating for DNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
6 days ago · accessnewswire.com
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...

2 weeks ago · accessnewswire.com
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues - - Intra-Quarter Investor Conference Call and Webcast Scheduled for June ...

4 weeks ago · seekingalpha.com
Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call TranscriptGinkgo Bioworks Holdings, Inc. (NYSE:DNA ) Q1 2025 Results Conference Call May 6, 2025 5:00 PM ET Company Participants Daniel Marshall - Sr. Manager, Communications and Ownership Jason Kelly - Co-Foun...

1 month ago · businesswire.com
Twist Bioscience Spins Out DNA Data Storage as Independent CompanySOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...